
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+8
Castle Creek Biosciences is a late-stage company developing re-dosable gene therapies. It is preparing to launch a pivotal clinical trial of its lead candidate, D-Fi, for patients with dystrophic epidermolysis bullosa (DEB)
Gene therapy,rare disease,clinical research,drug development,dermatology,epidermolysis bullosa,life sciences,personalized medicine,biotechnology,genetics,orphan drug,pediatric disease,and bioscience
Castle creek biosciences, inc operates in the Biotechnology research industry.
Castle creek biosciences, inc's revenue is 1m - 10m
Castle creek biosciences, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.